Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of …

JM Banales, V Cardinale, G Carpino… - Nature reviews …, 2016 - research.ed.ac.uk
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of
biliary tract differentiation. CCA is the second most common primary liver tumour and the …

Pathogenesis, diagnosis, and management of cholangiocarcinoma

S Rizvi, GJ Gores - Gastroenterology, 2013 - Elsevier
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte
differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar …

[HTML][HTML] Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma

A Lauterio, R De Carlis, L Centonze, V Buscemi… - Cancers, 2021 - mdpi.com
Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

[HTML][HTML] Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS …

JM Banales, V Cardinale, G Carpino… - Nature Reviews …, 2016 - nature.com
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of
biliary tract differentiation. CCA is the second most common primary liver tumour and the …

[PDF][PDF] Hepatocellular carcinoma‐associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4‐miR155‐SOCS1‐MMP9 axis

XL Yan, YL Jia, L Chen, Q Zeng, JN Zhou, CJ Fu… - …, 2013 - Wiley Online Library
Cancer‐associated mesenchymal stem cells (MSCs) play a pivotal role in modulating tumor
progression. However, the interactions between liver cancer‐associated MSCs (LC‐MSCs) …

Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks

J Vaquero, N Guedj, A Clapéron… - Journal of …, 2017 - Elsevier
Cholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to its late
clinical presentation and the lack of effective non-surgical therapies. Unfortunately, most of …

Calcium signaling in cancer progression and therapy

L Wu, W Lian, L Zhao - The FEBS journal, 2021 - Wiley Online Library
The old Greek aphorism 'Panta Rhei'('everything flows') is true for all living things in general.
As a dynamic process, calcium signaling plays fundamental roles in cellular activities under …

The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma

G Spolverato, MY Yakoob, Y Kim… - Annals of surgical …, 2015 - Springer
Background The influence of margin status on long-term outcome of patients undergoing
liver resection for intrahepatic cholangiocarcinoma (ICC) remains controversial. We sought …

[PDF][PDF] Platelet‐derived growth factor‐D and Rho GTPases regulate recruitment of cancer‐associated fibroblasts in cholangiocarcinoma

M Cadamuro, G Nardo, S Indraccolo, L Dall'Olmo… - …, 2013 - Wiley Online Library
Cholangiocarcinoma (CCA) is characterized by an abundant stromal reaction. Cancer‐
associated fibroblasts (CAFs) are pivotal in tumor growth and invasiveness and represent a …

Emerging molecular therapeutic targets for cholangiocarcinoma

S Rizvi, GJ Gores - Journal of hepatology, 2017 - Elsevier
Cholangiocarcinomas (CCAs) are diverse epithelial tumors arising from the liver or large
bile ducts with features of cholangiocyte differentiation. CCAs are classified anatomically …